Protagonist Therapeutics Inc (PTGX)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Dinesh V. Patel |
| Employees: | 120 |
| Web site: | protagonist-inc.com |
|
7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
(510) 474-0170
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Protagonist Therapeutics, Inc. discovers and develops peptide-based therapeutic drugs. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with polycythemia vera and hereditary hemochromatosis. PN-943, an oral, alpha-4-beta-7 integrin-specific antagonist peptide, is in clinical trials.
Please log in first to see chart